The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy

被引:17
|
作者
Carvalho, Tiago M. A. [1 ]
Cardoso, Henrique J. [1 ]
Figueira, Marilia I. [1 ]
Vaz, Cada V. [1 ]
Socorro, Silvia [1 ]
机构
[1] UBI, CICS, Hlth Sci Res Ctr, Covilha, Portugal
关键词
Cancer; Metabolism; Metastasization; Therapy; Tumour microenvironment; Metabolic waste; FATTY-ACID SYNTHASE; AUTOCRINE MOTILITY FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ATP-CITRATE LYASE; HIGH LACTATE LEVELS; PYRUVATE-KINASE M2; HYPOXIA INDUCIBLE FACTORS; SMALL-MOLECULE INHIBITOR; SUPPRESSES TUMOR-GROWTH; ADVANCED OVARIAN-CANCER;
D O I
10.1016/j.ejmech.2019.03.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The last decade has witnessed the peculiarities of metabolic reprogramming in tumour onset and progression, and their relevance in cancer therapy. Also, it has been indicated that the metastatic process may depend on the metabolic rewiring and adaptation of cancer cells to the pressure of tumour microenvironment and limiting nutrient availability. The present review gatherers the existent knowledge on the influence of tumour microenvironment and metabolic routes driving metastasis. A focus will be given to glycolysis, fatty acid metabolism, glutaminolysis, and amino acid handling. In addition, the role of metabolic waste driving metastasization will be explored. Finally, we discuss the status of cancer treatment approaches targeting metabolism. This knowledge revision will highlight the critical metabolic targets in metastasis and the chemicals already used in preclinical studies and clinical trials, providing clues that would be further exploited in medicinal chemistry research. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:343 / 363
页数:21
相关论文
共 50 条
  • [31] Cancer cell metabolism in the crosshairs: Targeting the mTOR pathway for cancer therapy
    Abraham, Robert T.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3624S - 3624S
  • [32] Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism
    DeLaBarre, Byron
    Hurov, Jonathan
    Cianchetta, Giovanni
    Murray, Stuart
    Dang, Lenny
    [J]. CHEMISTRY & BIOLOGY, 2014, 21 (09): : 1143 - 1161
  • [33] Cancer Metabolism as a Therapeutic Target
    Batra, Surabhi
    Adekola, Kehinde U. A.
    Rosen, Steven T.
    Shanmugam, Mala
    [J]. ONCOLOGY-NEW YORK, 2013, 27 (05): : 460 - 467
  • [34] Lung surfactant metabolism: early in life, early in disease and target in cell therapy
    Lopez-Rodriguez, Elena
    Gay-Jordi, Gemma
    Mucci, Adele
    Lachmann, Nico
    Serrano-Mollar, Anna
    [J]. CELL AND TISSUE RESEARCH, 2017, 367 (03) : 721 - 735
  • [35] Lung surfactant metabolism: early in life, early in disease and target in cell therapy
    Elena Lopez-Rodriguez
    Gemma Gay-Jordi
    Adele Mucci
    Nico Lachmann
    Anna Serrano-Mollar
    [J]. Cell and Tissue Research, 2017, 367 : 721 - 735
  • [36] New Cell Cycle Inhibitors Target Aneuploidy in Cancer Therapy
    Kawakami, Masanori
    Liu, Xi
    Dmitrovsky, Ethan
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59, 2019, 59 : 361 - 377
  • [37] Peculiarities of metabolism of glycoconjugates in monitoring of ovarian cancer treatment
    Knyazyeva, M.
    Prokopyuk, A.
    Babaeva, O.
    [J]. FEBS JOURNAL, 2006, 273 : 262 - 262
  • [38] CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy
    Shademan, Behrouz
    Karamad, Vahidreza
    Nourazarian, Alireza
    Avci, Cigir Biray
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (03) : 476 - 489
  • [39] DEFECTIVE CELL MATURATION AN ALTERNATIVE TO ACCELERATED CELL DIVISION AS TARGET FOR CANCER THERAPY
    SETALA, K
    [J]. PROGRESS IN EXPERIMENTAL TUMOR RESEARCH, 1964, 5 : 1 - &
  • [40] Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
    Sobanski, Thais
    Rose, Maddison
    Suraweera, Amila
    O'Byrne, Kenneth
    Richard, Derek J.
    Bolderson, Emma
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9